Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma
2000

Chemotherapy and Radiotherapy for Nasopharyngeal Cancer

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Benasso M, Sanguineti G, D'Amico M, Corvò R, Ricci I, Numico G, Guarneri D, Vitale V, Pallestrini E, Santelli A, Rosso R

Primary Institution: Istituto Nazionale per la Ricerca sul Cancro, Genova

Hypothesis

Can adding effective chemotherapy to concomitant chemo-radiotherapy improve results in stage IV undifferentiated nasopharyngeal carcinoma?

Conclusion

Induction chemotherapy followed by alternating chemo-radiotherapy is feasible and shows promising activity in treating locally advanced undifferentiated nasopharyngeal carcinoma.

Supporting Evidence

  • All patients were evaluable for toxicity and response.
  • At the end of the induction phase, 10% of patients achieved complete responses.
  • At a median follow-up of 31 months, 13.3% of patients had loco-regional progression.

Takeaway

Doctors tried a new way to treat a type of throat cancer by using both chemotherapy and radiation together, and it worked pretty well.

Methodology

Patients received induction chemotherapy followed by alternating courses of chemotherapy and radiation.

Limitations

The study had a small sample size and was not a phase III trial.

Participant Demographics

30 patients with untreated T4 and/or N2–3 undifferentiated nasopharyngeal carcinoma.

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1485

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication